Therapy outcomes of IL-17 and JAK inhibitors in rosacea:A systematic review
Xinyi Dai
Chenxingyue Zhang
Zhiqiang Yin
Department of Dermatology,the First Affiliated Hospital of Nanjing Medical University,Nanjing,Jiangsu 210029,China
摘要：Dear Editor,
Rosacea is characterized by persistent or transient erythema,papules,pustules,telangiectasia,and/or phymatous lesions[1].Although multiple treatments are available for rosacea,the advent of biological agents and small-molecule agents has significantly advanced our ability to target the disease more effectively[2].In the current review,we summarize the outcomes of targeted therapies in rosacea,mainly focusing on interleukin(IL)-17 inhibitors and Janus kinase(JAK)inhibitors.
机标关键词：inhibitorsreviewoutcomesrosaceasystematictherapy
分类号：R758.734(皮肤病学与性病学)
论文发表日期：2025-05-30
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：2( 317-318 )